Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 42.63% is 346% above its 5-year average of -17.31%, near the high end of its 5-year range (-156.92%–60.09%).
15.62% above its 12-month average of 36.87%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 29.95%.
OPERATING MARGIN
42.63%
OPERATING MARGIN AVG TTM
36.87%
OPERATING MARGIN AVG 3Y
16.18%
OPERATING MARGIN AVG 5Y
-17.31%
OPERATING MARGIN AVG 10Y
-35.22%
OPERATING MARGIN AVG 15Y
-94.76%
OPERATING MARGIN AVG 20Y
-85.76%
CURRENT VS TTM AVG
+15.62%
CURRENT VS 3Y AVG
+163.52%
CURRENT VS 5Y AVG
+346.32%
CURRENT VS 10Y AVG
+221.03%
CURRENT VS 15Y AVG
+144.99%
CURRENT VS 20Y AVG
+149.71%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Rigel Pharmaceuticals, Inc.
Market Cap
$853.13M
Operating Margin
42.63%
TTM Avg
36.87%
3Y Avg
16.18%
5Y Avg
-17.31%
Market Cap
$852.35M
Operating Margin
-174.65%
TTM Avg
-105.11%
3Y Avg
-66.40%
5Y Avg
-66.40%
Market Cap
$855.38M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$857.16M
Operating Margin
-30.67%
TTM Avg
-52.06%
3Y Avg
-18.41%
5Y Avg
7.25%
Market Cap
$867.03M
Operating Margin
-8.31%
TTM Avg
-16.09%
3Y Avg
-30.50%
5Y Avg
-38.64%
Market Cap
$838.62M
Operating Margin
-348.46%
TTM Avg
-328.22%
3Y Avg
-265.67%
5Y Avg
-226.03%
Market Cap
$838.16M
Operating Margin
-69.75%
TTM Avg
-70.49%
3Y Avg
-9306.05%
5Y Avg
-9306.05%
Market Cap
$870.81M
Operating Margin
-5415.19%
TTM Avg
-5415.19%
3Y Avg
-5415.19%
5Y Avg
-5415.19%
Market Cap
$833.81M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals, Inc. (RIGL) | $853.13M | 42.63% | 36.87% | 16.18% | -17.31% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -174.65% | -105.11% | -66.40% | -66.40% |
| Alumis Inc. (ALMS)vs › | $855.38M | -1776.32% | -888.16% | -444.08% | -444.08% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -30.67% | -52.06% | -18.41% | 7.25% |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -8.31% | -16.09% | -30.50% | -38.64% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | -348.46% | -328.22% | -265.67% | -226.03% |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | -69.75% | -70.49% | -9306.05% | -9306.05% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | -5415.19% | -5415.19% | -5415.19% | -5415.19% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | -43.83% | -75.55% | -37.77% | -25.18% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
91.4%
Operating Margin
42.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 29.95% |
| 2026-03-31 | 20.21% |
| 2025-12-31 | 33.19% |
| 2025-09-30 | 40.91% |
| 2025-06-30 | 60.09% |
| 2025-03-31 | 23.95% |
| 2024-12-31 | 28.92% |
| 2024-09-30 | 25.41% |
| 2024-06-30 | 1.21% |
| 2024-03-31 | -23.59% |
| 2023-12-31 | 5.49% |
| 2023-09-30 | -15.87% |
| 2023-06-30 | -19.59% |
| 2023-03-31 | -48.81% |
| 2022-12-31 | 4.05% |
| 2022-09-30 | -82.12% |
| 2022-06-30 | -43.48% |
| 2022-03-31 | -156.92% |
| 2021-12-31 | -104.94% |
| 2021-09-30 | -91.84% |
| 2021-06-30 | -49.68% |
| 2021-03-31 | 51.54% |
| 2020-12-31 | -102.04% |
| 2020-09-30 | -74.94% |
| 2020-06-30 | -108.56% |
| 2020-03-31 | 37.71% |
| 2019-12-31 | -112.58% |
| 2019-09-30 | -57.71% |
| 2019-06-30 | -205.04% |
| 2019-03-31 | -145.58% |
| 2018-12-31 | 6.69% |
| 2018-09-30 | -500.92% |
| 2018-06-30 | -1461.16% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | -1983.89% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | -452.06% |
| 2016-12-31 | -526.23% |
| 2016-09-30 | -604.76% |
| 2016-06-30 | -158.81% |
| 2016-03-31 | -349.31% |
| 2015-12-31 | -149.31% |
| 2015-09-30 | -52.18% |
| 2015-06-30 | -269.56% |
| 2015-03-31 | -837.51% |
| 2014-12-31 | -271.13% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -294.68% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | -1634.64% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | -1658.80% |
| 2012-03-31 | -3108.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | -414.26% |
| 2011-06-30 | -5457.47% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 15.74% |
| 2010-09-30 | 69.67% |
| 2010-06-30 | 54.55% |
| 2010-03-31 | -685.37% |
| 2009-12-31 | -3346.93% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | -253.21% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | -1053.48% |
| 2007-03-31 | -689.79% |
| 2006-12-31 | -540.09% |
| 2006-09-30 | -207.72% |
| 2006-06-30 | -25.20% |
| 2006-03-31 | -99.19% |
| 2005-12-31 | -167.54% |
| 2005-09-30 | -419.77% |
| 2005-06-30 | -274.21% |
| 2005-03-31 | -436.55% |
| 2004-12-31 | -1354.73% |
| 2004-09-30 | -2476.18% |
| 2004-06-30 | -842.43% |
| 2004-03-31 | -882.31% |
| 2003-12-31 | -563.72% |
| 2003-09-30 | -525.30% |
| 2003-06-30 | -441.08% |
| 2003-03-31 | -167.82% |
| 2002-12-31 | -215.89% |
| 2002-09-30 | -276.51% |
